Categories
-
Adhesives
1
Amines
53
Amino Acids
159
Analytical Reagents
211
Antibiotics
174
APIs
509
Aroma Chemicals
128
Biochemicals
608
Boronic Acids
2
Buffers
58
Building Blocks
936
Carbohydrates
117
Chiral Compounds
45
Detergents
40
Diagnostic Raw Materials
104
Flavours and Fragrance Materials
77
Fluorinated Products
32
Furans
7
Gases in Solution
39
Grignard Reagents
1
HPLC Reagents
1
Imidazoles
15
Indoles
43
Inorganic Chemicals
124
Ligands
63
Organics
552
Oxazoles
3
Peptide Reagents
46
Phenols
24
Picolines
0
Piperazines
12
Pyrazines
2
Pyridines
46
Pyrimidines
23
Quaternary Ammonium salts
24
Reagents
40
Research Organics & Inorganics
465
Salts
138
Sealing Compounds
0
Sherclin
0
Solvents
63
Stains & Indicators
208
Sugars
56
Testing Standards
2
Uncategorised
0
Water Analysis
4
Ofloxacin
(11654280 | 82419-36-1)
| CAS: | 82419-36-1 |
|---|---|
| Molecular Formula: | C18H20FN3O4 |
| Molecular Weight: | 361.37 |
| Availablility: | In Stock |
|---|---|
| Downloads: | Product Specification | Safety Data Sheet [EN] |
| 11654280-5g | 5g | £46.70 | |
| Bulk Order | |||
| 11654280-5g | 5g | €70.05 | |
| Bulk Order | |||
| 11654280-5g | 5g | $84.06 | |
| Bulk Order | |||
Safety Data Sheet
Certificate of Analysis
Product Detail
| Product Code | 11654280 | ||||
| Product Name | Ofloxacin | ||||
| Categories | Antibiotics APIs | ||||
| CAS | 82419-36-1 | ||||
| Molecular Formula | C18H20FN3O4 | ||||
| Molecular Weight | 361.37 | ||||
| Storage Details | 2 to 8 °C | ||||
| Harmonised Tariff Code | 29349990 |
Product Specification
| Specific rotation | -1° to +1° | ||||
| Total impurity | 0.5% max | ||||
| Heavy metals | <10ug/g | ||||
| Arsenic | 1ug/g max | ||||
| Loss on Drying | 0.2% max | ||||
| Specification | USP | ||||
| Assay | 98.5% | ||||
| Ethanol | 0.05% max | ||||
| Methanol | 0.005% max | ||||
| Residue on Ignition | 0.1% max | ||||
| Individual impurity | 0.3% max | ||||
| Appearance | White to yellow light crystalline powder |
Safety Information
| Pictograms |
|
||||
| Signal word | none | ||||
| Hazard statements |
|
||||
| Precautionary statements |
|